Brian Grady represents public and private companies in complex domestic and cross-border mergers, acquisitions, divestitures, joint ventures, and corporate restructurings. He brings extensive experience across the industrials, manufacturing, technology, building products, and life sciences sectors, advising clients on high-stakes transactions and helping them navigate deal complexities with practical, business-minded counsel. Brian takes a hands-on approach to every engagement, working closely with clients to develop tailored strategies that address both immediate transaction needs and long-term business objectives.
Brian's recent representative experience includes advising TriMas in the $1.45 billion sale of its Aerospace business; Hexagon AB in the €2.7 billion sale of its Design & Engineering business to Cadence Design Systems; STERIS in the $787.5 million sale of its Dental business to Peak Rock Capital and in its $3.6 billion acquisition of Cantel Medical; Avient Corporation in the $1.485 billion acquisition of DSM's protective materials business and in the $950 million sale of its Distribution business; EssilorLuxottica in the formation of its SightGlass Vision joint venture with CooperCompanies; TopBuild Corp. in its acquisition of American Building Systems Group; and Materion Corporation in its $160 million acquisition of Optics Balzers, AG.
Brian maintains an active pro bono practice, counseling Ohio nonprofit organizations regarding tax-exempt status and corporate governance issues, serves on the board of directors of Cleveland Play House, and previously served on the board of directors of the Downtown Cleveland Alliance.
经验
- University of Minnesota (J.D. magna cum laude 2014; Articles Submission Editor, Minnesota Law Review; ABA-BNA Award in Health Law, 2014; M.P.H. 2014); Case Western Reserve University (B.A. in Biology cum laude 2009)
- Ohio
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice